GLP-1 drugs may reduce risk of heart failure in diabetes

03/11/2013 | DoctorsLounge.com

Diabetes patients who took GLP-1 drugs were 41% less likely than those who took other glucose-lowering drugs to be hospitalized for heart failure, a study presented at the American College of Cardiology meeting indicated. Patients on GLP-1 drugs also had a 44% reduced risk of hospitalization for any reason and 80% lower risk of all-cause mortality compared with those on other diabetes medications, researchers said.

View Full Article in:

DoctorsLounge.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY